Blood biomarkers of amyloid and tau pathologies, brain degeneration, inflammation, and oxidative stress in early‐ and late‐onset Alzheimer's disease

Documents similaires

• Characterizing molecular and synaptic signatures in mouse models of late‐onset Alzheimer's disease independent of amyloid and tau pathology
  par: Kevin P. Kotredes, et autres
  Publié: (2024)
• Plasma insulin is an early biomarker of amyloid‐β pathology in Alzheimer’s disease
  par: Yuhan Chen, et autres
  Publié: (2024)
• Mesial temporal tau pathology impacts basal forebrain degeneration in early Alzheimer's disease
  par: Ying Xia, et autres
  Publié: (2025)
• Aging x Environment x genetic risk for late onset Alzheimer’s disease results in alterations in cognitive function in mice independent of amyloid and tau pathology
  par: Sean‐Paul Gerard Williams, et autres
  Publié: (2024)
• The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology
  par: Eric M. McDade, et autres
  Publié: (2025)